mTORC1 signaling contributes to drinking but not blood pressure responses to brain angiotensin II

Endocrinology

Volumn 157, Issue 8, 2016, Pages 3140-3148

  Muta, Kenjiro ^a   Morgan, Donald A ^a   Grobe, Justin L ^a,b   Sigmund, Curt D ^a,b   Rahmouni, Kamal ^a,b  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR TYPE 1; ANGIOTENSIN II; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; RAPAMYCIN; UNCLASSIFIED DRUG; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; FLUID BALANCE; FLUID INTAKE; HORMONE ACTION; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NERVE CELL; NONHUMAN; ONCOGENE C FOS; POLYDIPSIA; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SUBFORNICAL ORGAN; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; BRAIN; C57BL MOUSE; DRINKING; DRUG EFFECTS; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRAIN; DRINKING; DRINKING BEHAVIOR; FEMALE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84982797786     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1243     Document Type: Article

References (37)

1. O'Callaghan EL, Choong YT, Jancovski N, Allen AM. Central angiotensinergic mechanisms associated with hypertension. Auton Neurosci. 2013;175:85-92.
2. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest. 2000;106:103-106.
3. Sakai K, Agassandian K, Morimoto S, et al. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest. 2007;117:1088-1095.
4. Okuno T, Nagahama S, Lindheimer MD, Oparil S. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril. Hypertension. 1983;5:653-662.
5. Evered MD, Robinson MM, Richardson MA. Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain. Eur J Pharmacol. 1980;68:443- 449.
6. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274-293.
7. Hafizi S, Wang X, Chester AH, Yacoub MH, Proud CG. ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am J Physiol Heart Circ Physiol. 2004;287: H1232-H1238.
8. Eguchi S, Iwasaki H, Ueno H, et al. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem. 1999;274:36843-36851.
9. Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res. 1995;77:1040-1052.
10. Caron A, Baraboi ED, Laplante M, Richard D. DEP domain-containing mTOR-interacting protein in the rat brain: distribution of expression and potential implication. J Comp Neurol. 2015;523: 93-107.
11. Gonzalez AD, Wang G, Waters EM, et al. Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience. 2012;226: 489-509.
12. Morimoto S, Cassell MD, Sigmund CD. Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J Biol Chem. 2002;277: 33235-33241.
13. Li B, Lee K, Martin RJ. Overexpression of glucose transporter 2 in GT1-7 cells inhibits AMP-activated protein kinase and agouti-related peptide expression. Brain Res. 2006;1118:1-5.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
15. Muta K, Morgan DA, Rahmouni K. The role of hypothalamic mTORC1 signaling in insulin regulation of food intake, body weight, and sympathetic nerve activity in male mice. Endocrinology. 2015;156:1398-1407.
16. Harlan SM, Guo DF, Morgan DA, Fernandes-Santos C, Rahmouni K. Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab. 2013;17:599-606.
17. Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441:1-21.
18. Yano N, Suzuki D, Endoh M, Zhao TC, Padbury JF, Tseng YT. A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells. J Biol Chem. 2007;282:18819-18830.
19. Shibata S, Arroyo JP, Castañeda-Bueno M, et al. Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation. Proc Natl Acad Sci USA. 2014;111: 15556-15561.
20. Liao YM, Sy A, Yen Y. Markers for efficacy of mammalian target of rapamycin inhibitor. Anticancer Res. 2012;32:4235-4244.
21. Coble JP, Grobe JL, Johnson AK, Sigmund CD. Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ. Am J Physiol Regul Integr Comp Physiol. 2015;308:R238-R249.
22. Northcott CA, Watts S, Chen Y, Morris M, Chen A, Haywood JR. Adenoviral inhibition of AT1a receptors in the paraventricular nucleus inhibits acute increases in mean arterial blood pressure in the rat. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1202-R1211.
23. Ballou LM, Lin RZ. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008;1:27-36.
24. Llewellyn T, Zheng H, Liu X, Xu B, Patel KP. Median preoptic nucleus and subfornical organ drive renal sympathetic nerve activity via a glutamatergic mechanism within the paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol. 2012;302:R424-R432.
25. Hilzendeger AM, Cassell MD, Davis DR, et al. Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension. Hypertension. 2013;61:716-722.
26. Jo F, Jo H, Hilzendeger AM, et al. Brain endoplasmic reticulum stress mechanistically distinguishes the saline-intake and hypertensive response to deoxycorticosterone acetate-salt. Hypertension. 2015;65:1341-1348.
27. Appenzeller-Herzog C, Hall MN. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 2012;22:274-282.
28. Camacho A, Rodriguez-Cuenca S, Blount M, et al. Ablation of PGC1 β prevents mTOR dependent endoplasmic reticulum stress response. Exp Neurol. 2012;237:396- 406.
29. Di Nardo A, Kramvis I, Cho N, et al. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTORdependent manner. J Neurosci. 2009;29:5926-5937.
30. Coble JP, Johnson RF, Cassell MD, Johnson AK, Grobe JL, Sigmund CD. Activity of protein kinase C-α within the subfornical organ is necessary for fluid intake in response to brain angiotensin. Hypertension. 2014;64:141-148.
31. Nazarewicz RR, Salazar G, Patrushev N, et al. Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-α-dependent Akt activation in endosomes. J Biol Chem. 2011; 286:2886-2895.
32. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol. 2003;139:191-202.
33. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol. 2009;296:H1425-H1433.
34. Makadia HK, Anderson WD, Fey D, Sauter T, Schwaber JS, Vadigepalli R. Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology. Biophys J. 2015;108:211-223.
35. Gulati P, Gaspers LD, Dann SG, et al. Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab. 2008; 7:456- 465.
36. Young CN, Davisson RL. Angiotensin-II, the brain, and hypertension: an update. Hypertension. 2015;66:920-926.
37. Peterson JR, Burmeister MA, Tian X, et al. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension. 2009;54:1106-1114.